Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
US9745295B2 · kind B2 · utility
0Cited by
21References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 22, 2014 |
| Grant date | Aug 29, 2017 |
| Priority date | — |
| Expiry date | Apr 22, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, and R4 are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.